MedPath

Comparison between two anaesthetic drugs Propofol and Ketamine during anaesthesia in Electro Convulsive Therapy in treatment of depressive disorders.

Not yet recruiting
Conditions
Major depressive disorder, recurrent, severe with psychotic symptoms,
Registration Number
CTRI/2019/05/018890
Lead Sponsor
Armed Forces Medical College
Brief Summary

This study is a prospective, single blind, randomized control trial comparing the effects of Propofol and Ketamine in modified ECT which will be conducted in a tertiary care hospital in India. The ECT sessions will be randomized in two groups of 22 each. The first group will be given Propofol as the induction agent and the second group will be given Ketamine as the induction agent. As per their randomization each patient will be given inj Propofol 1.5 mg/kg iv or inj Ketamine 0.8-1.2 mg/kg iv. The primary objective will be comparison of duration of seizure (both motor and EEG) between Propofol and Ketamine.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

All patients of age more than 18 yrs scheduled for ECT.

Exclusion Criteria
  • Patients not giving consent 2.
  • Raised intracranial pressure 3.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
comparison of Duration of seizure (both motor and EEG) between Propofol and Ketamine when used in modified ECToutcome will be assessed immediately after administering the drug till the time the seizure will last.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Armed Force Medical College

🇮🇳

Pune, MAHARASHTRA, India

Armed Force Medical College
🇮🇳Pune, MAHARASHTRA, India
Dr Debarshi Guha
Principal investigator
8879526556
drdebarshi.guha@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.